Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2019

Achieving tight control of a photoactivatable Cre recombinase
gene switch: New design strategies and functional
characterization in mammalian cells and rodent
Kyle Meador
University of Colorado

Christina L. Wysoczynski
University of Colorado

Aaron J. Norris
Washington University School of Medicine in St. Louis

Jason Aoto
University of Colorado

Michael R. Bruchas
University of Washington - Seattle Campus

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Meador, Kyle; Wysoczynski, Christina L.; Norris, Aaron J.; Aoto, Jason; Bruchas, Michael R.; and Tucker,
Chandra L., ,"Achieving tight control of a photoactivatable Cre recombinase gene switch: New design
strategies and functional characterization in mammalian cells and rodent." Nucleic Acids Research. 47,17.
. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8351

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Kyle Meador, Christina L. Wysoczynski, Aaron J. Norris, Jason Aoto, Michael R. Bruchas, and Chandra L.
Tucker

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/8351

Published online 9 July 2019

Nucleic Acids Research, 2019, Vol. 47, No. 17 e97
doi: 10.1093/nar/gkz585

Kyle Meador1,† , Christina L. Wysoczynski1,† , Aaron J. Norris2 , Jason Aoto1 , Michael
R. Bruchas3 and Chandra L. Tucker1,*
1

Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA, 2 Department of
Anesthesiology, Division of Basic Research, Washington University School of Medicine, St Louis, MO 63110, USA
and 3 Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA

Received April 04, 2019; Revised June 05, 2019; Editorial Decision June 21, 2019; Accepted June 24, 2019

ABSTRACT

INTRODUCTION

A common mechanism for inducibly controlling protein function relies on reconstitution of split protein
fragments using chemical or light-induced dimerization domains. A protein is split into fragments that
are inactive on their own, but can be reconstituted
after dimerization. As many split proteins retain affinity for their complementary half, maintaining low activity in the absence of an inducer remains a challenge. Here, we systematically explore methods to
achieve tight regulation of inducible proteins that
are effective despite variation in protein expression
level. We characterize a previously developed split
Cre recombinase (PA-Cre2.0) that is reconstituted
upon light-induced CRY2-CIB1 dimerization, in cultured cells and in vivo in rodent brain. In culture,
PA-Cre2.0 shows low background and high induced
activity over a wide range of expression levels, while
in vivo the system also shows low background and
sensitive response to brief light inputs. The consistent activity stems from fragment compartmentalization that shifts localization toward the cytosol. Extending this work, we exploit nuclear compartmentalization to generate light-and-chemical regulated versions of Cre recombinase. This work demonstrates
in vivo functionality of PA-Cre2.0, describes new approaches to achieve tight inducible control of Cre
DNA recombinase, and provides general guidelines
for further engineering and application of split protein fragments.

Since the first understanding that split fragments of a protein could complement each other, allowing restoration of
biological activity (1–3), methods utilizing complementation or reconstitution of split protein fragments have been
widely used for sensor and protein control applications. Although some split protein fragments have sufficient affinity to assemble on their own, protein fragments that do not
self-assemble can be fused to proteins that interact, allowing
conditional reconstitution of activity due to the increased
proximity (4,5).
When utilized in live cells, split proteins have most commonly been used as reporters to detect interacting proteins.
Some of the earliest split protein sensors were transcription
factors with modular DNA binding and activation domains
that could be split and functionally reconstituted through
a protein–protein interaction (6). Another early-developed
split protein sensor was ubiquitin, which when reconstituted
can allow binding of a ubiquitin protease and coincident
cleavage of a reporter (4). Subsequently, split forms of many
other reporter proteins have been developed, including split
DHFR, GFP and other fluorescent proteins, Cre recombinase, beta-lactamase and luciferase (5,7–9).
While split proteins have been most widely adopted for
use as reporters of protein interaction, similar designs can
also be used to control protein activity using light or a chemical switch to induce proximity. In this scenario, each half of
a split enzyme or other protein is attached to one partner of
a protein pair that conditionally dimerizes. Chemically induced dimerization systems, in which domains are brought
together by a chemical ligand (10), have been applied to a
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MATERIALS AND METHODS
Cloning and mutagenesis
Full sequences of constructs used in this manuscript and
primers used for cloning are provided in Supplementary Table S1. All CreN constructs contain residues 19–104 of Cre
DNA recombinase, while CreC constructs contain residues
106–343. The constructs mCh-IRES-CRY2(L348F)-CreN
(p688) and mCh-IRES-CIB1-CreC (p645) were described
previously (14). The constructs mCh-IRES-CRY2FL(wt)CreN (p221), CRY2FL(+NLS)-mCherry (p950) and the
loxP-STOP-loxP-EGFP reporter are described in Kennedy
et al., (27). The DIO-EGFP reporter (p1053) was generated by digesting pcDNA3.1+ with EcoRI and EcoRV enzymes, then inserting a DIO-EGFP cassette (containing
loxP2272-loxP-invertedEGFP-loxP2272-loxP) from pAAVCAG-DIO-EGFP using EcoRI and AfeI sites.
To generate KM10, CIB1-CreC-IRES-CRY2(L348F)CreN-IRES-mCh, an intermediate construct (p941, CIB1CreC-IRES-CRY2(L348F)-CreN-stop-mCh) was first generated. To generate this, CIB1-CreC(N1) was digested with
EcoRV and XmaI, and CIB1-CreC-IRES-CRY2(L348F)CreN cut at EcoRV-XmaI sites from plasmid GFP-P2ACIB1-CreC-IRES-CRY2(L348F)-CreN was inserted (both
plasmids are described in Taslimi et al 2016). Next, the
IRES element from p688 was polymerase chain reaction
(PCR)-amplified (primers 1889f/1890r), and ligated into
p941 cut with XmaI. To generate p985 (CRY2(L348F)CreN-IRES-mCh), KM10 was digested with XhoI and religated to excise the CIB1-CreC-IRES insert. To generate KM60 (CRY2(L348F)-CreN-IRES-CIB1-CreC-IRESmCh), first the CIB1-CreC-IRES insert was cut out from
KM10 using AfeI and SalI and blunt-ended with T4
DNA polymerase. This insert was ligated into a version of p985 with the KpnI site mutated, cut with ClaI
(blunt fill in). To generate p1116, CIB1-CreC-IRES-mCh,
KM10 was digested with KpnI then religated, excising
the IRES-CRY2(L348F)-CreN insert. To generate KM10
pA, KM10 was digested with SbfI and AflII (blunt fill)
and ligated to an insert containing IRES-mCherry amplified with 1677f/687r then digested with SbfI and EcoRV.
To generate the myc-tagged constructs, for p926,
CRY2(L348F)-CreN was PCR-amplified to add a Nterminal myc tag (primers 1683f/1685r, then 1684f/1685r),
then cloned into p688, replacing CRY2(L348F)-CreN
at SacI and XmaI sites. To generate p1108, the L348F
mutation in CRY2 was mutagenized to wild-type (L348L)
using one-step Phusion mutagenesis protocols from New
England Biolabs. Briefly, oligos containing the 348L
substitution (1145r/2109f) were used to amplify the entire
plasmid using Phusion High-Fidelity DNA Polymerase
(NEB), then the PCR products were treated by T4 Polynucleotide Kinase (NEB) in the presence of ATP at 37◦ C for
30 min before self-ligation using T4 Quick Ligase (NEB).
To generate p1133, CRY2(L348F) was PCR amplified (primers 654f/639r) using p985 as template and digested with NheI and XmaI, then ligated into pmCherryN1 at NheI and XmaI sites. To generate p1089 (mChCRY2(L348F)-CreN), a NheI-XmaI fragment containing
CRY2(L348F)-CreN was ligated at NheI/XmaI sites into
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range of protein targets. More recently, light induced dimerization systems have also been developed that accomplish
similar functions, but with the benefits of spatial regulation
and reversibility (11,12). Such split protein approaches have
been used to conditionally control activity of proteins such
as Cre recombinase (13–15), transcriptional activators (16–
19), and proteases (20–22). In a recent study, a computational scoring approach to facilitate design of ideal protein
split sites was developed and used to conditionally control
activity of several split signaling proteins (23).
Two main strategies have been used to regulate biological function with split proteins. A protein with independent separable domains can be split between these domains,
as in the case of a transcription factor DNA binding domain and activation domain (6). In this case, the modular
domains do not interact and are functionally independent,
and the dimerization simply serves to tether the activation
domain in proximity to the DNA binding element. In many
other cases, however, a protein does not have independent
domains. Splitting such proteins yields fragments that may
retain substantial affinity even under non-inducing conditions. Affinity of these fragments is required to reconstitute
protein function, but can contribute to background activity. A key parameter for tight inducible control of these proteins is the concentration of the protein fragments in the cell:
self-assembly under non-induced conditions is more likely
to occur as the protein concentration of the fragments increases. To circumvent this issue, several different strategies
have been taken. First, fragment interfaces can be disrupted
to reduce interaction affinity (4,22). Second, protein expression level can be precisely controlled. Third, an additional
layer of inducible control can be added to the regulated system (24–26).
While a number of different strategies have been found to
be effective, few detailed studies of parameters affecting activity of inducible split proteins have been performed. Here,
we systematically examine the effects of modulating expression and localization of split protein fragments used to generate a light activatable Cre DNA recombinase (PA-Cre2.0)
(14). We find that high light activity and low dark background can be achieved by expressing one half of the split
Cre system at extremely low levels. With increased expression, background activity of PA-Cre2.0 increases, but remains remarkably low compared to other split Cre recombinase systems. In vivo, PA-Cre2.0 also shows remarkably low
dark activity and robust response to short light inputs. We
establish that the low dark background of PA-Cre2.0 results
from alterations in nuclear-cytosolic shuttling in one of the
split Cre fragments, resulting in a reduced fraction of protein in the nucleus as overall protein expression increases.
This work suggests a design strategy for achieving tight light
regulation of inducible dimerization systems through tuning nuclear import/export signals to reduce sensitivity to
expression level differences. Extending this approach, we
demonstrate dual control of Cre recombinase activity by
controlling nuclear localization or abundance using a small
molecule and assembly of split fragments using light, providing more complex control of DNA recombination for a
diverse range of applications.
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(primers 1926f/1890r) and the insert digested with KpnI
and XmaI, then ligated into p986 digested with KpnI and
XmaI. To generate AAV constructs, myc-CRY2(L348F)CreN or CIB1-CreC were cloned into AAV-CaMKII-GFP
at KpnI and BsrGI sites (where GFP was removed).
Cell culture experiments
HEK293T cells were maintained in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) at 37˚C with 5% CO2 . To test split
constructs, 1 g (or indicated amounts) of the loxP-STOPloxP-EGFP Cre recombinase reporter (or DIO-EGFP reporter, where indicated) and each split fragment were transfected into HEK293T cells on 12-well plates using standard calcium phosphate transfection methods. Nonspecific
‘stuffer’ DNA was included in transfections as needed to ensure all transfection wells received equal amounts of DNA.
Cells were wrapped in aluminum foil after transfection and
kept in dark for 24 h before blue light treatment (461 nm
delivered from custom-built LED arrays, 7.4–18 mW/cm2 ).
For extended light treatment, 2 s pulses were delivered every
3 min, or as indicated in figures. Dark samples were kept in
the dark throughout the experiment. Cells were imaged to
quantify reporter fluorescence 24 h after initial onset of light
treatment (48 h after transfection), unless specified otherwise.
For immunoblotting, cells were harvested 24 h after transfection, washed in 1× phosphate-buffered saline
(PBS), and lysed in 2× Laemmli sample buffer with boiling. Proteins were separated by electrophoresis on an
sodium dodecyl sulphate-polyacrylamide gelelectrophoresis gel and transferred to nitrocellulose membranes, followed by probing with primary (anti-Cre recombinase,
Novusbio NB100-56135; anti-tubulin, Li-COR, 926-42213;
anti-myc tag, Sigma M4439) and secondary (goat antirabbit IR-Dye 800CW, LiCOR, 926-32211; goat antimouse IR-Dye 680RD, Li-COR, 926-68070) antibodies. An
Odyssey FC Imager (Li-COR) was used to visualize labeled
immunoblots.
Cre recombinase quantification and statistical comparison
Quantification of Cre DNA recombinase activity was carried out in live cells using a Leica DM IL LED Fluo microscope with L5 ET and TX2 ET filters. Images were taken
with an iPhone7 (Apple) equipped with an iDu microscope
adaptor (iDu Optics) and visualized using ImageJ. The
percent of transfected cells (typically expressing mCherry)
showing EGFP reporter activity was quantified from images using CellProfiler (https://cellprofiler.org) (28) or manual count, and is indicated in graphs as ‘% Cre recombination’. Significance for experiments comparing two populations was determined using a two-tailed unpaired student’s
t-test.
Image analysis
For localization studies, HEK293T cells were seeded onto
coverslips in 12-well plates, transfected with specified plasmid DNA, then harvested after 24 h. Coverslips were fixed
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a modified version of pmCherryC1 (Clontech) in which
the linker between BsrGI and SacI had been replaced
by the sequence agggaggtggaggtgctagc, containing a NheI
site in place of SacI. To generate CW53, CRY2FL was
isolated from p1108 at EcoRI and NotI sites, then ligated into p1089 at the same sites. To generate p1097,
mCh-CRY2(L348F)-CreC, the NotI-XmaI fragment from
CIB1-CreC (containing CreC) was inserted into p1089 digested with NotI and XmaI. To generate p1103 (mChCRY2(L348F)-NLS-CreN), a nuclear localization signals
(NLS) was first added to the C-terminus of CRY2(L348F)
by PCR (primers 1677f/2130r) using p688 as template. This
fragment was ligated into p688 cut with SacI and NotI. To
generate p1105, the CRY2(L348F)-NLS-CreN insert from
p1103 was cut out (EcoRI and XmaI sites) and ligated into
p1097 digested with EcoRI and XmaI. To generate CW184,
the C-terminus of p1089 was modified by PCR to mutate
the putative NES sequence using primers 1290f/2985f then
1290f/2986r. The insert was digested with NotI and XmaI
and ligated into p1089 at the same sites.
To generate p1087 (mCh-CIB1-CreN), a NotI-XmaI
fragment containing CreN was isolated from p688 and
ligated into KM69 at NotI/XmaI sites. To generate
KM69 (mCh-CIB1-CreC(106)-IRES-Cry2(L348F)-CreN),
the mCh-CIB1-CreC(106)-IRES-CRY2(L348F)-CreN insert was isolated from p1071 (SpeI/XmaI sites). The insert was ligated into pmCherryC1 cut with NheI and
XmaI. To generate p1117 (mCh-CIB1-CreC), KM69 was
digested with KpnI and SmaI to remove the IRESCRY2(L348F)-CreN fragment, then religated. To generate
KM91 (mCh-IRES-Magnet-PA-Cre), a SnaBI-SacI fragment from p688 (containing the mCherry-IRES insert)
was ligated into Magnet PA-Cre (pcDNA3.1 backbone)
(15). To generate p1115 (CIB1-CreN), a NotI-XmaI fragment containing CreN was ligated into CIB1-CreC(N1) at
NotI/XmaI sites. To generate p1088/KM75 (mCh-IRESCRY2(L348F)-CreC), a NotI-XmaI fragment containing
CreC was ligated into p688 at NotI/XmaI sites.
To generate CW40, CRY2(L348F)-CreN was PCRamplified from p1089 (primers 2197f/2198r), then digested with KpnI and XhoI for cloning into pcDNA-NESPhoCI-mCherry (Campbell lab, Addgene #87690) at KpnI
and XhoI sites. CW59 was generated by PCR amplifying (primers 2264f/1081r) the PhoCl-CRY2(L348F) insert
from CW40. The insert was cut with XhoI and EcoRI and
ligated into p688 previously cut with XhoI and EcoRI.
CW57 was made using primers 2278f/2279r to amplify
a human estrogen receptor ligand binding domain insert,
which was digested with SacI and ligated into CW59 cut
with SacI. To generate CW79, the ecDHFR insert from
pBMN DHFR(DD)-YFP (Wandless lab, Addgene #29325)
was PCR amplified (primers 2561f/2562r) to add ClaI and
SalI ends. The insert was ligated into p688 cut with ClaI and
SalI.
To
generate
p989,
CRY2(L348F)-CreN-P2ACIB1-CreC-IRES-mCh, p688 was amplified by PCR
(1689f/1924r, then 1689f/1925r) to add a P2A sequence
at the C-terminus of CRY2(L348F)-CreN. This insert was
digested with EcoRI and KpnI, then ligated into p985
digested with EcoRI and KpnI to generate intermediate
clone p986. In a second step, KM10 was PCR amplified
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Production of AAVs for in vivo injection
To generate AAVs for injection, we used the AAV-DJ strain.
HEK293T cells were co-transfected with each AAV plasmid along with helper plasmids (pDJ and pHelper) using
calcium phosphate transfection. Seventy-two hours posttransfection cells were harvested, lysed and purified over an
iodixanol gradient column (2 h at 400 000 × g in a Beckman Type80Ti rotor). The virus was collected, dialyzed to
remove excess iodixanol and aliquoted and stored at −80◦ C
until use.
In vivo studies in mouse
Adult Ai14 mice containing an integrated CAG-loxPSTOP-loxP-tdTomato cassette at the Gt(ROSA)26Sor locus were stereotactically injected with a 1:1:1
volume/volume mixture of AAV constructs (AAVCaMKII-myc-CRY2(L348F)-CreN, AAV-CaMKII-CIB1CreC, and AAV-hSyn-EYFP) into the dentate gyrus.
AAV-CaMKII-myc-CRY2(L348F)-CreN (titer 9.52 × 1011
GC/ml) and AAV-CaMKII-CIB1-CreC (titer 1.53 × 1012
GC/ml) were packaged at the University of Colorado.
AAV-hSyn-EYFP virus was obtained from the University
of North Carolina viral core (https://www.med.unc.edu/
genetherapy/vectorcore/) with a titer of 3.3 × 1012 GC/ml.
For injection, mice were anesthetized with 2% isoflurane,
skin prepped and opened and a small hole was created
in the skull at designated coordinates using a high-speed
drill and burr. A total of 300 nl viral solution was injected

into the dentate gyrus. After injection, a fiber optic was
implanted above the injection site and secured using
meta-bond dental cement. Animals were left to recover for
3 weeks post-surgery. Animals were connected to a patch
cable and a 473 nm laser light source to provide light to
brain tissue. The output at the end of the patch cable was
measured at 15 mW prior to connection to implanted fiber.
Fiber optic implants were made in house with the minimum
acceptable efficiency of 80% (29). Animals were treated
with light (1 s pulse of light through the implanted fiber
optic or no light for control treated animals. One week after
light treatment, mice were transcardially perfused with 4%
paraformaldehyde. The brains were collected, sectioned
and imaged using a Leica DM6 fluorescent microscope.
RESULTS
PA-Cre recombinase activity correlates with CRY2-CreN expression level
We previously generated a photoactivatable Cre DNA recombinase (PA-Cre2.0) in which N- and C-terminal fragments of Cre recombinase were fused to interacting partner
proteins, Arabidopsis thaliana photoreceptor cryptochrome
2 (CRY2) and CIB1, a protein that interacts with lightstimulated CRY2 (14). In dark, CRY2 and CIB1 have low
affinity and the fused N- and C-terminal fragments of Cre
do not functionally assemble. In light, the fragments are
brought into proximity through light-induced dimerization,
promoting assembly and functional reconstitution of recombinase activity. To increase the sensitivity of the system to allow high activity in response to brief light input,
we also included a L348F mutation on CRY2 that extends
the photoexcited state, thus allowing extended interaction
of CRY2 with CIB1 after light exposure (14). While PACre2.0 showed low background and robust light response,
our initial studies did not examine how activity would be altered by differences in expression of split protein fragments
or determine the optimal expression level of the system. One
drawback of many split protein systems is that the affinity
of the N- and C-terminal fragments, required for induced
assembly and reconstitution of activity, can contribute to
background activity in an expression-dependent manner
(11,22). Although our initial choice of split Cre recombinase fragments (CreN, residues 19–104; CreC, residues 106–
343) showed minimal self-assembly when expressed at moderate levels in the cell (14), we had not tested at very high
expression.
As a first step to test and improve the system, we sought
to equalize expression of the CreN and CreC fragments by
generating a bicistronic vector using a P2A cleavable peptide tag. We avoided tagging the CIB1-CreC fragment (i.e.
CIB1-CreC-P2A-CRY2-CreN) as the cistron upstream of
the P2A peptide retains a 18-residue tag at the C-terminus,
and CIB1-CreC was previously found to be intolerant of
an epitope tag at this site (14). Unfortunately, placement
of a P2A tag downstream of CRY2(L348F)-CreN (p989)
substantially reduced recombinase activity (Supplementary
Figure S1). We next tested bicistronic vectors in which the
CIB1-CreC and CRY2(L348F)-CreN fragments were separated by an IRES (internal ribosome entry site) element.
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in 4% paraformaldehyde, washed in 1 × PBS, then mounted
on a glass slide using Fluoromount-G (Southern Biotech).
Cells were imaged on an Andor Dragonfly 301 spinning disc
imaging system with Olympus IX73 base and four-line ILE
laser merge module and controller. Images were acquired
using a 60× UPlanSApo 1.35 NA oil objective, and collected on a 1024 × 1024 pixel Andor iXon EM-CCD camera. Data acquisition and analysis were performed with Fusion (Andor) and ImageJ software.
After initial image collection, ImageJ 1.45s was used for
all image analysis. For nuclear:cytoplasmic ratio quantification, confocal image Z-stacks were compiled into a maximal projection. Total fluorescence in either the nucleus or
cytosol was calculated by manually selecting either the nucleus or cytosolic region of interest and quantifying average
fluorescence and area within these compartments. A separate region of the image was used to calculate background,
which was subtracted from the average fluorescence. Average fluorescence was multiplied by area and calculated for
nuclear vs cytosolic regions, then these were divided to obtain a ratio of nuclear:cytoplasmic protein. To quantify nuclear concentration versus total cell fluorescence for Figure
2G, the mean intensity of fluorescence in the nucleus was
background subtracted and reported on the X-axis. The total cell fluorescence on the Y-axis was defined by multiplying each cell area (manually selected) by the background
subtracted average fluorescence intensity. Values depicted
for each are arbitrary units. Significance for experiments
comparing two populations was determined using a twotailed unpaired student’s t-test.
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teract increasingly, resulting in higher dark background activity. Interestingly, when we had originally characterized
the PA-Cre2.0 system, we observed that dark background
was significantly reduced when using L348F CRY2-CreN
compared with wt CRY2-CreN, however we had not compared activity of these constructs at different expression levels. When we reduced the expression of wt CRY2-CreN in
cells, both L348F and wt versions showed similar activity
(Figure 1G). Thus, while PA-Cre with wt CRY2 was highly
dependent on expression level, the L348F variant appeared
to confer activity that was remarkably buffered from expression level differences.
L348F mutation of PA-Cre2.0 alters nuclear localization to
reduce dark background
To further investigate the low dark background of PACre2.0, we focused on the L348F mutation. When generating PA-Cre2.0, we had added this mutation, which extends the photocycle, to allow reconstitution of the split
fragments for a longer period of time in response to a short
light pulse (14). Given that the CRY2 photocycle phenotype would not be expected to manifest in dark, the exceptionally low background activity in dark (Figure 1G) was
unexpected, suggesting L348F was also affecting CRY2 in
another way. We first hypothesized that the mutation could
destabilize the CRY2-CreN fragment, but observed no difference in steady-state protein levels between wt and L348F
versions (Figure 2A).
We next examined whether the L348F substitution affects
CRY2 subcellular localization, as both CRY2-CreN and
CIB-CreC fragments must localize to the nucleus to catalyze
DNA recombination. When designing the PA-Cre, to enable nuclear localization of each fragment we used versions
of CRY2 and CIB1 that retain endogenous NLS found near
the C-terminus of each protein (27). Indeed, while mCherrytagged wt CRY2 was strongly nuclear, L348F CRY2 showed
a reduced proportion of protein in the nucleus (Figure 2B).
These results suggest that the L348F substitution could alter exposure of the CRY2 NLS, or interfere with its interaction with import machinery.
We next examined the localization of the full length
fragment (CRY2-CreN fusion), using mCherry-tagged versions. With both L348F and wt CRY2, the presence of the
CreN fragment resulted in further reduced nuclear localization (Figure 2C), suggesting adding this domain either
reduced nuclear import or increased nuclear export. Using
NetNES 1.1 prediction software (31), we identified a predicted nuclear export consensus sequence (NES) ‘LQARGLAV’ at residues 78–85 of Cre recombinase, which resides in the CreN fragment. We hypothesized that this motif and the L348F mutation act additively to restrict levels of CRY2(L348F)-CreN in the nucleus, resulting in the
low background activity observed. Indeed, mutating the
critical ‘LxV’ of the predicted NES to ‘LQARGAAA,’ to
yield CRY2(L348F)-CreN(NES) resulted in significantly
increased nuclear localization (Figure 2C). When we added
a strong SV40 NLS to CRY2(L348F)-CreN (Figure 2C), we
also observed an increase in nuclear localization, along with
a corresponding increase in dark background activity (Figure 2D). Likewise, switching the CreN and CreC domains of
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A version containing CIB1-CreC upstream, KM10 (CIB1CreC-IRES-CRY2(L348F)-CreN), showed good functionality in a single construct (Figure 1A and B). Using this construct, we were able to achieve ∼80% recombination rate in
cells treated with just three pulses of light (4s duration each)
spaced 45 min apart (Supplementary Figure S2). However,
we also observed that the CRY2-CreN fragment in this construct was expressed at a much lower level than the CIB1CreC fragment (Figure 1C), potentially limiting the system.
Because the cistron downstream of an IRES element often expresses at lower levels (30), and since CRY2 is often expressed more poorly than CIB1, we hypothesized that
switching the order of the proteins within the IRES construct (e.g. CRY2(L348F)-CreN-IRES-CIB1-CreC, KM60)
may equalize fragment expression and improve function.
This configuration resulted in higher levels of expressed
CRY2-CreN compared with CIB1-CreC (Figure 1C), but
no functional improvement, showing elevated dark background with no improvement in light activity (Figure 1B).
Given the significant differences in dark activity resulting
from altering the ratio of CRY2(L348F)-CreN and CIB1CreC, we undertook a systematic characterization of the
effect of modulating expression level of each split protein
half. Using separate plasmids to express each fragment,
we tested the CreN or CreC components (CRY2(L348F)CreN or CIB1-CreC), positioning each fragment either
upstream or downstream of an IRES element to manipulate expression level. To quantify activity, we included
a mCherry fluorescent reporter in the opposing position (i.e. mCherry-IRES-CIB1-CreC) (Figure 1D). Thus,
we tested high-expressing CreC (CIB1-CreC-IRES-mCh,
p1116, +++), low-expressing CreC (mCh-IRES-CIB1CreC, p645, +), high-expressing CreN (CRY2(L348F)CreN-IRES-mCh, p985, +++) and low-expressing CreN
(mCh-IRES-CRY2(L348F)-CreN, p688, +). Altering the
expression level of CIB1-CreC had no significant effect on
either dark or light activity (Figure 1E). In contrast, increasing CRY2(L348F)-CreN expression resulted in a significant
increase in dark background activity, with minimal effect on
light activity. Combined, these results suggested a correlation between increased CRY2(L348F)-CreN expression and
dark background.
Since our studies indicated we could maintain high light
activity but reduce dark activity by reducing CRY2(L348F)CreN expression, we explored whether we could decrease
expression of this fragment further. A construct (pA)
identified during cloning that lacked much of the polyA
termination signal results in nearly undetectable levels of
CRY2-CreN protein as assayed by immunoblot (Figure
1F), due to the loss of much of the 3 UTR that acts to stabilize the mRNA. Despite the substantially lower levels of expressed protein, pA showed similar light-induced activity
as KM10 and minimal dark background activity (1.3% dark
recombination, compared with 5.1% for KM10). These results suggested that high levels of expression of PA-Cre2.0
were not required for maintaining high activity.
The minimal change to light and dark activity over such
a large range of expression levels was surprising, given that
the split protein fragments are expected to retain moderate affinity for each other in order to reassemble. As expression increases, the fragments would be expected to in-
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Figure 1. Alteration of expression level of CRY2-CreN and CIB1-CreC fragments causes changes in dark background, with minimal effects on lightinduced activity. (A) Schematic showing combined constructs used in (B) and (C). (B) Quantification of Cre recombinase activity in HEK293T cells. Cells
expressing CRY2(L348F)-CreN in front of an IRES element (KM60) show higher dark background compared with KM10. Cells were transfected with
indicated plasmids and a loxP-STOP-loxP-EGFP reporter, then kept in dark and harvested at 48 h. Light-treated samples were exposed to a 4 s pulse of
light at 24 h. Graph shows average and error (s.d., n = 4–6 independent experiments). (C) Immunoblot comparing expression of Cre fragments in KM10
versus KM60 (anti-Cre antibody, top panel; anti-tubulin, bottom panel). (D) Immunoblots of dual plasmid system. HEK293 cells were transfected with
indicated constructs and immunoblotted with an anti-Cre antibody (top). Bottom panel shows anti-tubulin loading control. Control lane consisted of
non-transfected cells. (E) Quantification of Cre recombinase activity in HEK293T cells transfected with indicated constructs and light-treated as in (B).
Protein expression level as determined in (D) is indicated below the graph, with ‘+’ (low expression) or ‘+++’ (high expression). Graph shows average
and error (s.d., n = 3–5 independent experiments). (ns, not significant; *, P < .05, student’s t-test). (F) Comparison of expression level and activity of
HEK293T cells expressing a combined PA-Cre2.0 construct (KM10), or an identical version (pA) with a mutant polyadenylation signal. Expression of
the Cre fragments is greatly reduced in the pA version. Dark background activity is significantly reduced (*, P < .05), but no significant difference in lightstimulated activity is observed. Graph shows average and error (s.d., n = 3–6 independent experiments). (G) Quantification of Cre recombinase activity
with different amounts of wt or L348F CRY2-CreN. All samples contained 1 g EGFP Cre reporter and 1 g p645 (CIB1-CreC) and were quantified 48
h post-transfection. Light samples received a 4 h light exposure at 24 h (2 s pulse every 1 min, 461 nm). Samples labeled ‘high’ were transfected with 1 g
of L348F or wt CRY2-CreN; ‘low’ samples contained 50 ng. Graph shows average and range of two independent experiments.

the constructs, to generate mCherry-CRY2(L348F)-CreC
(p1097) and mCherry-CIB1-CreN (p1087), resulted in constructs with predominantly nuclear localization (Figure
2E), but also higher dark background compared with the
original system (Figure 2F).
To more precisely explore the differences between wt or
L348F versions of CRY2-CreN, we imaged the mCherrytagged fragments and quantified the concentration of pro-

tein in the nucleus as total protein expression increased (Figure 2G). With both wt and L348F CRY2, the concentration of protein in the nucleus increased as total cell fluorescence increased. At all expression levels, the concentration of L348F CRY2-CreN in the nucleus was lower than wt
CRY2-CreN. These results support that the reduced dark
background of L348F is due to reduced nuclear localization and buffering of protein in the cytosol as protein ex-
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of Cre recombinase activity in cells expressing CRY2(L348F)-CreN/CIB1-CreC (‘original’) or CRY2(L348F)-CreC/CIB1-CreN (‘switched’) versions of
PA-Cre. Both mCherry-fused and non-fused versions of CIB1-CreN were assayed and results combined. Data represents average and error (s.d., n = 4–
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nuclear occupancy.
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Comparison of PA-Cre2.0 with Magnet-actuated PA-Cre
We hypothesized that the unique design of PA-Cre2.0 may
provide an advantage over other split systems that are
strongly nuclear localized, such as the Magnet PA-Cre system (15), which has a strong SV40 NLS attached to each Cre
half. Mag PA-Cre uses a similar split fragment approach,
but uses nMag/pMag (‘Magnet’) photodimerizers and a
different Cre split site (15). To directly compare these two
systems, we placed Mag PA-Cre downstream of a mCherryIRES element (i.e. mCh-IRES-MagPA-Cre, KM91) and
used a EGFP DIO (Double-floxed Inverse Open reading
frame) Cre reporter (32), allowing quantification of Cre activity by recording the number of mCherry-expressing cells
with EGFP expression. We tested the responses of both systems in side-by-side experiments in dark, or after exposure
to 4 s or 4 h blue light (Figure 3).
Because different dimerizer-induced split protein systems
have different optimal expression levels, it is essential to explore a range of expression levels when comparing different systems. Previous studies with Mag PA-Cre indicated
that the optimal dynamic range of the system required substantially lower expression, as these prior experiments used
much lower amounts of transfected Mag PA-Cre DNA
(typically, a 1:9 ratio of Mag PA-Cre to Cre reporter was
used) (15). We tested equivalent conditions as previously
used, using a 1:9 ratio of Mag PA-Cre relative to the Cre
reporter and transfected similar amounts of DNA (50 ng
MagPA-Cre, 450 ng DIO reporter) (Figure 3A). In turn,
we tested expression of CRY2/CIB1 PA-Cre2.0 under similar expression conditions (50 ng PA-Cre2.0 and 450 ng reporter). We compared these results at low expression levels
with results at higher expression using 20-fold more DNA
(1 g PA-Cre and 1 g reporter). At the higher expression level, the Mag PA-Cre showed high background, but
this was dramatically reduced at the lower (optimized) expression level. The CRY2/CIB-actuated PA-Cre2.0 system
performed equally well at both high (1:1 ratio Cre:reporter,
1g PA-Cre2.0) and low (1:9 ratio, 50 ng PA-Cre2.0) levels. At the low (1:9) expression level, Mag PA-Cre showed
higher dark background and reduced light-induced stimulation compared with PA-Cre2.0, resulting in lower overall dynamic range (ratio of activity in light/dark was 6.8
for Mag PA-Cre, compared with 154.5 for CRY/CIB PACre2.0). When compared using expression levels optimized
for each system (1:1 ratio for PA-Cre2.0; 1:9 ratio for Mag
PA-Cre), PA-Cre2.0 also showed enhanced dynamic range
and higher levels of recombination in response to a short
4 s light pulse (Figure 3B). We also note that these results

showing high activity of CRY2/CIB1 PA-Cre2.0 with the
DIO reporter indicate this system is able to catalyze recombination events at non-canonical loxP sites, which has not
been previously demonstrated.
In vivo validation of PA-Cre2.0
The consistent activity afforded by PA-Cre2.0 in cell culture, with minimal background even at higher expression
levels, suggested the system would be well-suited for use
in vivo. We thus tested the system with viral delivery in
vivo in mouse brain, expressing each Cre half in an AAV
vector and using a CaMKII promoter to impart neuronal
expression (pAAV-CaMKII-myc-CRY2(L348F)-CreN and
pAAV-CaMKII-CIB1-CreC). To visualize induced recombinase activity in mouse, we used Ai14 Cre reporter mice,
which contain an integrated loxP-flanked STOP cassette
preventing transcription of a CAG promoter-driven tdTomato reporter (33). These mice express tdTomato fluorescent protein upon Cre mediated-recombination.
Ai14 mice were stereotactically injected in the dentate
gyrus with virus comprising each of the two Cre halves, as
well as a hSyn-EYFP virus to mark the site of injection, as
shown in Figure 4A. Mice were implanted with an optical
fiber targeted directly above the injection site (Figure 4B).
Three weeks after injection and implantation, mice were either exposed to a 1 s pulse of blue (473 nm) light via a
patch cable connected to the implanted fiber, or no light
for control animals. Minimal expression of tdTomato was
observed in brains from control mice not exposed to the
blue light pulse (Figure 4C, top row). Brains from animals
treated with a 1 s light pulse showed tdTomato expression
in CaMKII positive neurons directly below the implanted
fiber (Figure 4C, bottom row). These results indicate low
background recombination can be achieved in vivo using virally delivered components. In addition, Cre recombination
can be effectively triggered in vivo as well as in vitro (cell culture) by a very brief light input (a single 1 s light pulse).
Manipulation of split Cre fragment nuclear localization for
tunable activity control
Our results indicated that expressing both Cre halves at high
levels in the nucleus is a major contributor to dark background activity, presumably due to the affinity of the two
split Cre fragments. We hypothesized that we could achieve
tighter control of activity by combining two inducible systems, wherein abundance or nuclear accumulation of the
CRY2-CreN fragment is manipulated by a first inducible
system, followed by light-induced fragment reconstitution.
In theory, by restricting the amount of CRY2-CreN fragment available for recombination until an inducible signal,
we could achieve very tightly controlled recombination activity with very low background. Such an approach has previously been used to improve dynamic range of split and
allosterically-controlled CRISPR switches (24,34).
To first test this concept, we fused the CRY2(L348F)CreN fragment to a destabilized Escherichia coli DHFR
that is unstable unless bound to the small molecule
trimethoprim (TMP) (35). Previous studies demonstrated
effective use of this domain to destabilize intact Cre re-
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pression levels increase overall. In Figure 2H we propose a
model of PA-Cre2.0 nuclear trafficking. The effect of combining a L348F CRY2 protein with reduced nuclear occupancy with a CreN fragment that promotes nuclear export
leads to a CreN version that is predominantly cytosolic, but
that undergoes nuclear shuttling. Thus, at any given time,
some fraction of the protein would be available in the nucleus to induce recombination with light. Because the majority of protein is buffered in the cytosol, we speculate that
such a design is less sensitive to expression level differences,
resulting in universally low dark background activity.
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combinase in mouse brain, with induced Cre function after delivery of TMP, a relatively inexpensive compound that
passes the blood-brain barrier (36). We generated ecDHFRCRY2(L348F)-CreN and tested activity of the recombinase
with or without prior addition of TMP (Figure 5A and B).
In the absence of TMP, we observed minimal activity in
dark or light (0.2% of cells showing recombination in dark,
2.3% in light). With 10 M TMP, we observed low background in dark (0.6%) but 29% of cells underwent recombination after a 30 min light treatment (delivered 20 min to 2
h after TMP addition).
As a second approach, we tested a method to trap
CRY2(L348F)-CreN in the cytosol and allow release with

light, by tethering to a NES-PhoCl construct. PhoCl is an
engineered protein derived from a mMaple fluorescent reporter that undergoes self-cleavage with 400 nm light application (37). We reasoned that fusion to NES-PhoCl could
trap the CRY2-CreN half in the cytosol in dark, but allow
release with UV light. However, we were unable to observe
any improvement in dynamic range of the system using this
approach (Supplementary Figure S3). Because 400 nm light
can stimulate CRY2-CRY2 self-association, we speculate
that the PhoCl light treatment could affect CRY2 nuclear
entry, but did not investigate this further.
In a similar approach to trap one of the fragments in
the cytosol, we next tested fusion of the CRY2(L348F)-
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CreN fragment to a human estrogen receptor alpha ligandbinding domain (ER␣-LBD). Steroid hormone LBDs such
as ER␣-LBD are effectively trapped in the cytosol in the
absence of ligand due to interaction with Hsp90. Addition of hormone releases the protein from Hsp90 and allows nuclear import (38). The ER␣-fused construct, ERCRY2(L348F)-CreN, showed minimal activity in light or
dark in the absence of 17-ß-estradiol, with 8-fold reduced dark background compared with CRY2(L348F)CreN (Figure 5C and D). In samples exposed to estradiol
but maintained in dark, background was also reduced (2.9%
recombination with ER fusion, compared with 4.2% without ER fusion). In turn, the addition of estradiol plus light
led to high activity, comparable to activity obtained without
the ER fusion. These results indicate that use of the ERLBD-fused CRY2-CreN fragment can further reduce dark
background, while enabling high levels of induced recombination with light plus hormone. Such a system (replacing
ER LBD with a tamoxifen-responsive variant) (39) may be
useful for in vivo studies, as it reduces potential dark background during long term expression and removes the requirement for samples to be maintained in dark at all times
prior to adding the ligand.
DISCUSSION
In this work, we systematically explored methods for
achieving tight control of activity of a split protein, photoactivatable Cre DNA recombinase, that would be effective over a wide range of protein expression levels. Photoactivatable Cre recombinase (PA-Cre2.0) consists of split
Cre protein fragments that are brought in proximity by a

light-dependent interaction between the plant photoreceptor CRY2 (containing a L348F mutation), and its binding
partner CIB1. We observed that activity of PA-Cre2.0 was
relatively insensitive to differences, in particular, in expression of the CRY2(L348F)-CreN fragment. We found that
insensitivity was due to reduced nuclear localization of this
fragment caused by a combination of two factors: weakening of the endogenous CRY2 nuclear localization by the
L348F mutation, and a cryptic NES identified in the CreN
fragment. With this combination, the protein is expected to
shuttle into and out of the nucleus, but is predominantly retained in the cytosol, resulting in steady but lower nuclear
levels than observed with the higher background wild-type
protein.
Our study provides new results showing that only very
low levels of protein and light are needed to achieve high
levels of Cre recombinase activity. We demonstrated that
high light induction (up to ∼80% of cells showing recombination) could be achieved using just three 4 s light pulses,
spaced 45 min apart. The system is also highly sensitive,
even when the fragments are expressed at very low levels. A RNA-destabilized version of PA-Cre2.0 (pA) that
produced protein levels that were nearly undetectable by
immunoblot nevertheless maintained high induced activity and low background in functional activity tests. Our results also unequivocally demonstrate that Cre recombinase
split at residue 105 is fully competent to catalyze recombination events at non-canonical loxP sites such as used in
DIO/FLEx recombinase reporters. A previous study (15)
had proposed that photoactivatable Cre recombinase split
at residue 105 was not competent to induce recombina-
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resulting in consistent function despite expression level variation in different cell types and organisms.
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